An Overview of the Worldwide Distribution of LRRK2 Mutations in Parkinson’s Disease
- 1 December 2023
- journal article
- review article
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 13 (6) , 335-350
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder with significant genetic influence. The LRRK2 gene is a major genetic contributor, particularly the Gly2019Ser mutation. This focused review...Keywords
This publication has 101 references indexed in Scilit:
- Genetic Variants of LRRK2 in Taiwanese Parkinson’s DiseasePLOS ONE, 2013
- North African Jewish and non-Jewish populations form distinctive, orthogonal clustersProceedings of the National Academy of Sciences, 2012
- Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease ModelsACS Chemical Neuroscience, 2012
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyThe Lancet Neurology, 2011
- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human NeuronsACS Chemical Biology, 2011
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2Nature Chemical Biology, 2011
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's diseaseNature Medicine, 2010
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseMovement Disorders, 2010
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- Lrrk2 mutations in South America: A study of Chilean Parkinson's diseaseNeuroscience Letters, 2007